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Abstract
Background: Type 2 diabetes is a serious problem for developed and developing countries. Prevention of prediabetes
progression to type 2 diabetes with the use of natural products appears to be a cost-effective solution. Zingiber mioga
has been used as a traditional food in Asia. Recent research has reported the potential health benefits of Zingiber mioga,
but the blood glucose reducing effect has not been yet evaluated.
Methods: In this study Zingiber mioga extracts (water and ethanol) were investigated for their anti-hyperglycemic and
antioxidant potential using both in vitro and animal models. The in vitro study evaluated the total phenolic content, the
oxygen radical absorbance capacity (ORAC) and the inhibitory effect against carbohydrate hydrolyzing enzymes (porcine
pancreatic α-amylase and rat intestinal sucrase and maltase) of both Zingiber mioga extracts. Also, the extracts
were evaluated for their in vivo post-prandial blood glucose reducing effect using SD rat and db/db mice models.
Results: Our findings suggest that the ethanol extract of Zingiber mioga (ZME) exhibited the higher sucrase and maltase
inhibitory activity (IC50, 3.50 and 3.13 mg/mL) and moderate α-amylase inhibitory activity (IC50, >10 mg/mL). Additionally,
ZME exhibited potent peroxyl radical scavenging linked antioxidant activity (0.53/TE 1 μM). The in vivo study using SD rat
and db/db mice models also showed that ZME reduces postprandial increases of blood glucose level after an oral
administration of sucrose by possibly acting as an intestinal α-glucosidase inhibitor (ZME 0.1 g/kg 55.61 ± 13.24 mg/dL)
Conclusion: The results indicate that Zingiber mioga extracts exhibited significant in vitro α-glucosidase inhibition and
antioxidant activity. Additionally, the tested extracts demonstrated in vivo anti-hyperglycemic effects using SD rat and
db/db mice models. Our findings provide a strong rationale for the further evaluation of Zingiber mioga for the potential
to contribute as a useful dietary strategy to manage postprandial hyperglycemia.
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Background
Non-insulin dependent diabetes mellitus (NIDDM, Type
2 diabetes) is a group of metabolic diseases marked by
high levels of blood glucose resulting from faults in insulin
resistance and insulin production [1–3]. Hyperglycemia, a
rapid rise in blood glucose levels in NIDDM patients oc-
curs due to hydrolysis of starch by pancreatic α-amylase
and absorption of glucose in the small intestine by α-
glucosidases such as sucrase and maltase [3]. Inhibition of
these carbohydrate-hydrolyzing enzymes can significantly
decrease the postprandial hyperglycemia after a mixed
carbohydrate diet and can be a key strategy in the control
of diabetes mellitus [4, 5]. However, a main negative
aspect of currently used therapeutic α-glucosidase inhibi-
tors, such as the drug acarbose, is the strong α-amylase
inhibitory activity causing abnormal bacterial fermentation
of undigested starch in the colon that leads to abdominal
distention, flatulence, meteorism and possibly diarrhea
[6, 7]. Recent studies showed that phenolic phytochemicals
from plant sources are natural inhibitors of α-amylase and
α-glucosidase [8, 9] Such natural inhibitors from dietary
plants could be useful since they have lower inhibitory ac-
tivity against α-amylase and a stronger inhibitory activity
against α-glucosidase and can be potentially used as an
effective strategy for the management of postprandial
hyperglycemia with minimal side effects [9].
Zingiber mioga (Zingiberaceae family) is a herb original
to eastern Asia. Its young flower buds have been used as a
traditional food in Asia [10]. Recent research has reported
the antimicrobial activities of the constituents of Zingiber
mioga against several strains of bacteria, yeast, and mold
[11, 12]. The volatile ingredients of Zingiber mioga have
been studied; 2-isopropyl-3-methoxypyrazine, 2-sec-butyl-
3-methoxypyrazine, and 2-isobutyl-3-methoxypyrazine
were found to be the aroma compounds by GC-MS [1].
Additionally, mioga extract was effective in inhibiting fat
accumulation in 3 T3-L1 adipocytes leading to a decrease
in body weight gain and a decrease in fat mass in ICR
mice [2]. However, the significance of Zingiber mioga in-
take for preventing diabetes-related oxidative stress and
hyperglycemia is not reported. Based on the previous
obesity related findings, it is interesting to first evaluate
the in vitro potential of mioga extracts again carbohydrate
hydrolyzing enzyme using in vitro models and if inhibitory
effect is observed, then the extracts should be evaluated
using an animal model.
Therefore, the aim of this study is to examine the po-
tential effect and mechanism of action of Zingiber mioga
extract on the inhibition of postprandial hyperglycemia
using both in vitro and in vivo animal models. Clear
knowledge of the activity and mode of action of Zingiber
mioga extract will contribute towards better understanding
of the actual effect of various Zingiber mioga products
towards type 2 diabetes management. To determine the
above, in this study, we (i) prepared Zingiber mioga ex-
tracts (water extract of Zingiber mioga: ZMW, ethanol
extract of Zingiber mioga: ZME); (ii) investigated the
inhibitory activity of ZMW, ZME against α-amylase
and α-glucosidase (anti-hyperglycemia potential); (iii)
measured antioxidant potential using oxygen radical
scavenging capacity (ORAC) assay; and (iv) evaluated
the postprandial blood glucose lowering effect of ZMW,
ZME after sucrose loading in a Sprague-Dawley (SD) rat
and db/db mice model.
Methods
Chemicals
Zingiber mioga was obtained from a local market in Jeju,
Korea. The purchased samples were identified by one of
the authors (Young-In Kwon). A voucher specimen (BFC
O10985) was deposited at the Bioactive Food Components
Lab (BFCL) of the College of Life Science and Nano Tech-
nology, Hannam University. Rat intestinal acetone powder,
porcine pancreatic α-amylase enzyme powder, starch, su-
crose, and maltose were purchased from Sigma-aldrich
(St. Luis, MO, USA). Unless noted, all chemicals were
purchased from Sigma-aldrich (St. Luis, MO, USA).
Preparation of Zingiber mioga extracts
Water extraction
Zingiber mioga was crushed to a fine powder and was
extracted by autoclaving the ground leaves at 121 °C for
15 min with one gram-fresh weight per 40 mL of dis-
tilled water. Zingiber mioga extract was then centrifuged
at 8000 x g for 30 min, filtered through a Whatman # 1
filter, vacuum-evaporated at 60 °C, freeze dried and kept
at -20 °C refrigerator until analysis.
Ethanol extraction
Zingiber mioga was crushed to a fine powder and was
extracted by Shaking Incubation at 40 °C for 2 h with
one gram-fresh weight per 40 mL of ethanol. Zingiber
mioga extract was then centrifuged at 8000 x g for
30 min, filtered through a Whatman # 1 filter, vacuum-
evaporated at 60 °C, freeze dried and kept at -20 °C re-
frigerator until analysis.
Carbohydrate hydrolyzing enzyme inhibition
Porcine pancreatic α–amylase inhibition assay
Porcine pancreatic α-amylase inhibition was determined
by the method described by Kwon et al [3]. Sample solu-
tion (200 μL) and 0.02 M sodium phosphate buffer
(pH 6.9 with 0.006 M sodium chloride, 500 μL) contain-
ing α-amylase solution (0.5 mg/mL, 5.0 MU/mL) were
incubated at 25 °C for 10 min. After pre-incubation,
500 μL of a 1 % starch solution in 0.02 M sodium phos-
phate buffer was added. The reaction mixture was then
incubated at 25 °C for 10 min. The reaction was stopped
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with 1.0 mL of dinitrosalicylic acid (DNS). The reaction
mixture was then incubated in a boiling water bath for
5 min and cooled to room temperature. The reaction mix-
ture was then diluted after adding distilled water, and ab-
sorbance was measured at 540 nm with ELISA microplate
reader (SUNRISE; Tecan Trading AG, Saltzburg, Austria).









Sucrase and Maltase inhibition assay
The crude enzyme solution prepared from rat intestinal
acetone powder Sigma-Aldrich Co. (St. Louis, MO, USA)
was used as the small intestinal maltase, sucrase, and glu-
coamylase, showing specific activities of 0.70, 0.34 and
0.45 units/mL, respectively. Rat intestinal acetone powder
(1.0 g) was suspended in 3 mL of 0.9 % saline, and the sus-
pension was sonicated twelve times for 30 s at 4 °C. After
centrifugation (10,000 × g, 30 min, 4 °C), the resulting
supernatant was used for the assay. Sucrase and maltase
inhibitory activity were assayed by modifying a method
developed by Dahlqvist (1964) [4]. The inhibitory activity
was determined by incubating a solution of an enzyme
(50 μL), 0.1 M phosphate buffer (pH 7.0, 100 μL) contain-
ing 0.4 mg/mL sucrose or maltose or 1 % soluble starch,
and a solution (50 μL) with various concentrations of sam-
ple solution (between 0.05 mM and 1.0 mM) at 37 °C for
30 min. The reaction mixture was heated in a boiling water
bath to stop the reaction for 10 min, and then the amount
of liberated glucose was measured by the glucose oxidase
method [5]. The inhibitory activity was calculated from the
formula as follows. Inhibition (%) = (C-T)/C x 100, where C
is the enzyme activity without inhibitor and T is the en-
zyme activity with inhibitor.
Oxygen radical absorbance capacity (ORAC) assay
The peroxyl radical-scavenging capacities of Zingiber
mioga extracts were measured using ORAC [6, 7]. The
ORAC assay was carried out using a Tecan GENios
multi-functional plate reader (GENios; Tecan Trading
AG, Salzburg, Austria) with fluorescent filters (excita-
tion wavelength: 485 nm, emission filter: 535 nm). In
the final assay mixture, fluorescein (40 nM) was used as
a target of free radical attack with either 2, 2′-azobis (2-
amidinopropane) dihydrochloride (AAPH, 20 mM) as a
peroxyl radical generator in peroxyl radical-scavenging cap-
acity (ORACROO·) assay or with H2O2 - CuSO4 (H2O2,
0.75 %; CuSO4, 5 μM) as a hydroxyl radical generator in
hydroxyl radical-scavenging capacity (ORACHO·) assay.
Trolox (1 μM) was used as a control standard and prepared
fresh on a daily basis. The analyzer was programmed to
record the fluorescence of fluorescein every 2 min after
AAPH or H2O2 - CuSO4 was added. All fluorescence
measurements were expressed relative to the initial reading.
Final results were calculated based on the difference in the
area under the fluorescence decay curve between the blank
and each sample. All data were expressed as micromoles of
Trolox equivalents (TE). One ORAC unit is equivalent to
the net protection area provided by 1 μM of Trolox.
Total phenolic content assay
The total phenolic content was determined by an assay
modified from Velioglu et al. [8, 9]. One milliter of sample
solution was transferred into a test tube and mixed with
1 mL of 95 % ethanol and 5 mL of distilled water. To each
sample 0.5 mL of 50 % (v/v) Folin-ciocalteu reagent was
added and mixed. After 5 min, 1 mL of 5 % Na2CO3 was
added to the reaction mixture and allowed to stand for
1 h. The absorbance was read at 725 nm using spectro-
photometer (UV-160A; Shimadzu Inc., Kyoto, Japan). The
absorbance values were converted to total phenolics and
were expressed in mg equivalents of gallic acid/mL of the
sample. Standard curves were established using various
concentrations of gallic acid in 95 % ethanol.
Animal and study design
The inhibitory effect of Zingiber mioga extacts and acar-
bose on postprandial hyperglycemia after carbohydrate
loads in Sprague-Dawley (SD) rats and C57BL/KsJ-db/db
(db/db) mice were evaluated. The experimental proto-
cols followed were approved by the Institutional Animal
Care and Use Committee (IACUC) of the Hannam
University (Approval number: HNU2015-0004). Five
week-old male SD rats and C57BL/KsJ-db/db (db/db)
mice were purchased from Joongang Experimental Animal
Co. (Seoul, Korea) and fed a solid diet (Samyang Diet Co.,
Seoul, Korea) for 1 week. The rats and mice were housed
in a ventilated room at 25 ± 2 °C with 50 ± 7 % relative
humidity, and under an alternating 12 h light/dark cycle.
After 4 groups of 5 male SD rats and db/db mice were
fasted for 24 h, 2.0 g/kg of sucrose were orally admin-
istrated concurrently with 0 ~ 100 mg/kg inhibitors
(Zingiber mioga extracts or Acarbose). The blood sam-
ples were then taken from the tail after administration
and blood glucose levels were measured at 0, 0.5, 1,
and 2 h. The glucose level in blood was determined by
glucose oxidase method and compared with that of the
control group, which had not taken the inhibitors.
Statistical analysis
All data are presented as mean ± Standard deviation
(SD). Statistical analysis was carried out using statistical
package SPSS 10 (Statistical Package for Social Science;
SPSS Inc., Chicago, IL, USA) program and significance
of each group was verified with the analysis of on-way
analysis of variance (ANOVA) followed by the Duncan’s
test of p < 0.05.
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Results and discussion
Total phenolic contents in Zingiber mioga extracts
The total phenolic content in the two Zingiber mioga ex-
tracts (ZME; Ethyl alcohol extract of Zingiber mioga,
ZMW; Water extract of Zingiber mioga) was evaluated.
We determined that ZME had a total phenolic content
of 2697.31 mg/100 g which was higher than ZMW
(2182.96 mg/100 g) (Table 1). These results suggest that
ethanol is a more efficient solvent for phenolic com-
pounds extraction compared to water. Previous reports
have shown that the total polyphenol contents in extracts
has a positive correlation with observed anti-hyperglycemic
activity in diabetic rats [11]. Other studies using specific
phenolic compound standards such as caffeic acid, cate-
chins, anthocyanins, quercetins, and their derivatives con-
firmed their hypoglycemic effects in vitro and in vivo [12].
In vitro antioxidant capacity: peroxyl and hydroxyl radical
scavenging capacity
The antioxidant activity of Zingiber mioga extracts was
investigated for their radical-scavenging capacity using
the ORAC assay system. Figure 1 demonstrates that the
scavenging activity of Zingiber mioga extracts on peroxyl
radicals generated from AAPH is dose-dependent at
doses ranging from 1 to 10 μg/mL. The bars in Fig. 1a
represent the ORAC ROO· activity of 1 μM of the tested
sample equivalent to 1 μM Trolox, a water-soluble α-
tocopherol analogue. The ORAC value for the sample
extracts ranged from 0.53 ± 0.14 to 3.10 ± 0.10 μM of
TE. At all tested doses, ZME exhibited higher scaven-
ging activity on peroxyl radicals generated from AAPH
compared to ZMW (Fig. 1a). Furthermore, we evaluated
the hydroxyl radical absorbing activity (ORAC OH·) of
ZME and ZMW using ORAC assay in which Cu2+ and
H2O2 were used as hydroxyl radical generator. Similarly
to our previous findings, ZME had higher scavenging
activity compared to ZMW (Fig. 1b). Oxygen Radical
Absorbance Capacity (ORAC) assay system has been
used successfully to determine the reaction capacity with
peroxyl radical, one of the harmful and reactive oxygen
species in biological. ORAC assay has been employed
widely in testing foods and beverages to provide an inte-
grated and quantitative determination of “total antioxi-
dant capacity” (TAC). The ORAC value is obtained by
measuring the area under the curve (AUC) of the
magnitude and time of inhibition of free radical attack
on a fluorescent target molecule in reference to Trolox
(6-hydroxy-2,5,7,8-tetramethylchroman-2-carbonyl acid) as
a unit standard. Our findings suggest that the ethyl alcohol
extract has higher antioxidant potential than the water
extract. Phenolic compounds are well-documented radical
scavengers and our findings (Fig. 1) correlate with the ob-
served total phenolic contents (Table 1).
Sucrase and maltase inhibition
The dose-dependent sucrase inhibitory activities of ZME
and ZMW were evaluated as outlined in materials and
methods. The results showed that ZME exhibited signifi-
cantly higher sucrase inhibitory activities (Fig. 2). More
specifically, ZME had an IC50 value of 3.50 mg/mL,
while ZMW had 4.91 mg/mL (Table 2). When maltase
inhibitory activities were evaluated, similarly to sucrase
inhibitory activity, ZME had higher maltase inhibitory
activity (Fig. 3). More specifically, ZME and ZMW had
IC50 values of 3.13 mg/mL and 3.99 mg/mL, repsectively
(Table 2).
The enterocyte of the small intestine can only absorb
monosaccharaides such as glucose and fructose from
Table 1 Total phenolci content of Zingiber mioga extracts
Total phenolic contents (mg/100 g)
ZMW 2182.96 ± 48.02
ZME 2697.31 ± 118.25
ZMW: Water extract of Zingiber mioga
ZME: Ethanol extract of Zingiber mioga
Fig. 1 Dose dependent changes in peroxyl and hydroxyl radical
scavenging activities (Trolox equivalent, μM) of ZMW and ZME. a Peroxyl
radical scavenging activity of extracts; b hydroxyl radical scavenging
activity of extracts. The oxygen radical absorbance capacity (ORAC) value
is calculated by dividing the area under the sample curve by the area
under the Trolox curve, with both areas being corrected by subtracting
the area under the blank curve. One ORAC unit is assigned as the net
area of protection provided by Trolox at a final concentration of 1 μM.
The area under the curve for the sample is compared to the area
under the curve for Trolox, and the anti-oxidative value is expressed in
micromoles of Trolox equivalent per liter. The results represent the
mean ± SD. of values obtained from three measurements. Different
corresponding letters indicate significant differences at p < 0.05 by
Duncan’s test
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our diet. The intestinal absorption of dietary carbohy-
drates such as maltose and sucrose is supported by a
group of α-glucosidases, which include intestinal malt-
ase, sucrase, glucoamylase and isomaltase. Inhibition of
these enzymes can significantly decrease the postpran-
dial increase of blood glucose level after a mixed carbo-
hydrate diet [10]. Our results suggest that both extracts
resulted to significant inhibition of the evaluated carbo-
hydrate hydrolyzing enzymes. More specifically, when
looking at the dose-dependent inhibitory activity, we can
suggest that ZME had a higher inhibitory effect at the
5 mg/mL tested dose, which also results to a lower IC50
value. This observation could be due to the fact that etha-
nol extraction results to higher phenolic content when
compared to the water extraction. Previous reports have
clearly documented that carbohydrate hydrolyzing enzyme
inhibitory activity depends on phenolic content [13].
α-Amylase Inhibition of Zingiber mioga extracts
The dose-dependent inhibitory activity of the Zingiber
mioga extracts against porcine α-amylase was evaluated
in this study. As seen in Fig. 4, both samples exhibited
low α-amylase inhibitory activity, however ZME had a
higher α-amylase inhibitory activity (16.44 ± 2.95 %) than
ZMW (7.58 ± 2.28 %), (Fig. 1) at the same concentration
(10 mg/mL).
α-Amylase inhibitors could slow the liberation of maltose
from starch, resulting in delaying maltose conversion to
glucose and decreasing postprandial plasma glucose levels.
Previous reports with phenolic enriched herbal extracts
reported a link between α-amylase and α-glucosidase in-
hibitory activity [3, 14]. All the herb extracts showed a
comparable inhibition of α-glucosidase but did not have
any inhibitory activity against porcine pancreatic α-
amylase. Our findings are consistent with previous re-
ports, since we observed significantly lower α-amylase
inhibitory activity, compared to the sucrose and maltase
inhibitory activities.
Sucrose loading test in SD Rat and db/db mice model
To confirm the in vivo relevance of our in vitro findings
that ZME and ZMW extracts exhibited α-glucosidases
inhibitory activities, we performed a sucrose loading test
Table 2 Sucrase and maltase IC50 values of Zingiber mioga extracts
Sucrase (mg/mL) Maltase (mg/mL)
ZMW 4.91 3.99
ZME 3.50 3.13
ZMW: Water extract of Zingiber mioga
ZME: Ethanol extract of Zingiber mioga
Fig. 3 Dose-dependent changes in maltase inhibitory activities
(% inhibition) of ZMW and ZME. The results represent the mean ± S.D.
of values obtained from 3 measurements. Different corresponding
letters indicate significant differences at P < 0.05 by Duncan’s test. First
letter is among different samples and second one is among different
concentrations within same samples
Fig. 4 Dose-dependent changes in porcine pancreatic α-amylase
inhibitory activities (% inhibition) of ZMW and ZME. The results represent
the mean ± S.D. of values obtained from 3 measurements. Different
corresponding letters indicate significant differences at P < 0.05 by
Duncan’s test. First letter is among different samples and second
one is among different concentrations within same samples'
Fig. 2 Dose-dependent changes in sucrase inhibitory activities
(% inhibition) of ZMW and ZME. The results represent the mean ± S.D.
of values obtained from 3 measurements. Different corresponding
letters indicate significant differences at P < 0.05 by Duncan’s test. First
letter is among different samples and second one is among different
concentrations within same samples
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in SD rat, which is a model more relevant towards
type 2 diabetes prevention with normal or pre-diabetic
individuals, rather than type 2 diabetes treatments. In
SD rats, ZME (0.1 g/kg) exerted a statistically signifi-
cant decrease (p < 0.05) in the blood glucose at half an
hour after sucrose loading. ZME significantly reduced
(p < 0.05) the postprandial hyperglycemia caused by
sucrose loading to an extent less than that observed in the
acarbose (0.005 g/kg) administered group (p < 0.001)
(Fig. 5). However, ZMW had no significant effect (Fig. 5).
Furthermore, we evaluated the effect of ZME and ZMW
in 12 weeks db/db mouse model. Our observations sug-
gested that ZME (0.1 g/kg) exerted a statistically signifi-
cant decrease (p < 0.05) in the blood glucose at half an
hour after sucrose loading (Fig. 6). Similarly to our pre-
vious observations using SD rat model, ZMW had no
significant effect on the observed post-prandial blood
glucose levels (Fig. 6).
Our results demonstrate the positive effects of ZME
against post-prandial blood glucose levels resulting from
high sucrose meal ingestion. Our in vivo findings, correl-
ate with our in vitro observations, suggesting that ethanol
alcohol extraction is more efficient than water extraction.
More specifically, we have determined that ZME has
higher phenolic content that results to a higher in vitro
inhibition of carbohydrate hydrolyzing enzymes, when
compared to ZMW. These observations translate to a
higher in vivo efficacy of ZME.
Conclusions
A sudden increase in blood glucose levels, causing hy-
perglycemia in NIDDM is due to insulin’s inability to ef-
fectively utilize the glucose produced by the hydrolysis
of dietary carbohydrates by carbohydrate hydrolyzing
enzymes. Furthermore, hyperglycemia-induced microvascu-
lar complications are likely from oxidative dysfunction from
Fig. 5 Effect of ZMW and ZME on sucrose loading test. After fasting for 24 h, 6-week-old, male SD rats were orally administered with sucrose solution
(2.0 g/kg) with or without samples. Each point represents mean ± SD. (n = 5). *p < 0.05, **p < 0.01, and ***p < 0.001 compared to different samples at
the same concentration by unpaired Student’s t-test
Fig. 6 Effect of ZMW and ZME on sucrose loading test. After fasting for 24 h, 12-week-old, male db/db mice were orally administered with sucrose
solution (2.0 g/kg) with or without samples. Each point represents mean ± SD. (n = 5). *p < 0.05, **p < 0.01, and ***p < 0.001 compared to different
samples at the same concentration by unpaired Student’s t-test
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mitochondrial reactive oxygen species (ROS). There-
fore, it is important to control both cellular redox sta-
tus and blood glucose level for managing these diabetic
complications. The ethanol extract of Zingiber mioga
has α-glucosidase inhibitory activity and potent peroxyl
radical scavenging-linked antioxidant activity. Sucrose
loading test showed that ZME may reduce postprandial
increases of blood glucose level by acting as an intes-
tinal α-glucosidase inhibitor. The above dual benefits
(post-prandial blood glucose reduction and antioxidant
activity) of ZME could support the evidence that diet
rich in fruits and vegetables are associated with lower
incidences of oxidation-linked diseases such as diabetes
[15–17]. Furthermore, the Zingiber mioga extracts showed
a strong inhibition of α-glucosidase and low inhibition of
α-amylase and therefore could be potentially used as an
effective complementary therapy for postprandial hyper-
glycemia linked to type2 diabetes with reduced side effects
[18]. It is well documented that the major side-effects of
carbohydrate hydrolyzing enzyme inhibition are flatulence
and diarrhea resulting from the high α-amylase inhibitory
activity [19, 20].
These in vitro and in vivo studies provide the biochem-
ical rationale for the potential benefit of Zingiber mioga for
carbohydrate hydrolyzing enzyme inhibition, with ZME
appearing to be more bioactive. This observed higher effi-
cacy of ZME can be further enhanced by identifying the
bioactive components responsible for the observed ac-
tivity. Further investigation is underway to identify the
specific phenolic compounds in Zingiber mioga extrac-
tion that are relevant to the inhibition of carbohydrate
hydrolysis enzymes.
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